Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2010
10/26/2010CA2564684C Use of thioxanthene derivatives as chemosensitising compounds
10/26/2010CA2487270C Antimicrobial compositions, products and methods employing same
10/26/2010CA2409221C Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
10/26/2010CA2400700C Antiviral azaindole derivatives
10/26/2010CA2398707C C1 inhibitor produced in the milk of transgenic mammals
10/26/2010CA2372058C Hemisynthetic method of ecteinascidins and new intermediates
10/26/2010CA2327494C Novel crystalline forms of an antiviral benzimidazole compound
10/26/2010CA2135591C Stabilized oligonucleotides and their use
10/21/2010WO2010121247A1 Agr-mediated inhibition of methicillin resistant staphylococcus aureus
10/21/2010WO2010121225A2 Method of treating disorders associated with protein kinase ck2 activity
10/21/2010WO2010120621A1 Hepatitis c virus inhibitors
10/21/2010WO2010120195A1 Macrocyclic lactone combination compositions, vaccines and methods for producing same
10/21/2010WO2010119966A1 Antiviral agent and cleanser
10/21/2010WO2010119741A1 Preparation for external use
10/21/2010WO2010119638A1 Biofilm formation inhibitor
10/21/2010WO2010119161A2 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010WO2010118852A1 ( pyrazol-3-yl) -1, 3, 4-thiadiazol-2-amine and ( pyrazol-3-yl) -1, 3, 4-thiazol-2-amine compounds
10/21/2010WO2010056044A3 Novel compound acting as a vanilloid receptor antagonist, isomer or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same
10/21/2010WO2010026602A3 Pharmaceutical compositions containing calcium channel blockers for treatment of tuberculosis
10/21/2010WO2009136297A3 Fusion polypeptides comprising glycosylated mucin for inhibiting toxin a from clostridium difficile
10/21/2010WO2009126515A8 Compounds and compositions as protein kinase inhibitors
10/21/2010WO2009126514A8 Compounds and compositions as kinase inhibitors
10/21/2010US20100267833 Compositions and methods for preventing or treating an inflammatory response
10/21/2010US20100267805 Targeting opposite strand replication intermediates of single-stranded viruses by rnai
10/21/2010US20100267802 Delivery method
10/21/2010US20100267753 Methods of treating disorders associated with protein kinase ck2 activity
10/21/2010US20100267744 Pharmaceutical Compositions
10/21/2010US20100267741 Compounds, Compositions and Methods Comprising Pyrazole Derivatives
10/21/2010US20100267724 S-triazole alpha-mercaptoacetanilides as inhibitors of hiv reverse transcriptase
10/21/2010US20100267717 Novel Heterocyclic NF-kB Inhibitors
10/21/2010US20100267712 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses
10/21/2010US20100267711 Method of enhancing cellular production of molecular chaperone, hydroxylamine derivatives useful for enhancing the chaperone production and the preparation thereof
10/21/2010US20100267689 4-azetidinyl-1-phenyl-cyclohexane antagonists of ccr2
10/21/2010US20100267686 Carbacephem beta-lactam antibiotics
10/21/2010US20100267683 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field
10/21/2010US20100267678 Flux-enabling compositions and methods for dermal delivery of drugs
10/21/2010US20100267675 Compositions Comprising Sphingosine 1 Phosphate (S1P) Receptor Modulators
10/21/2010US20100267671 Compositions and methods for apoptosis modulators
10/21/2010US20100267668 4-azetidinyl-1-heteroatom linked-cyclohexane antagonists of ccr2
10/21/2010US20100267653 Use of coumarin derivatives in antifungal therapy
10/21/2010US20100267635 Use of protease inhibitors and grf molecules in combination therapy
10/21/2010US20100267634 Anti-Viral Compounds
10/21/2010US20100267633 N-(4-Oxo-3,4-Dihydroquinazolin-2Yl) Butanamides as Androgen Receptor Modulators
10/21/2010US20100267624 Vancomycin and teicoplanin anhydrous formulations for topical use
10/21/2010US20100267623 Peptides with capacity to bind to scurfin and applications
10/21/2010US20100267622 Methods to activate or block the HLA-E/Qa-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
10/21/2010US20100267621 Antimicrobial Compounds and Formulations
10/21/2010US20100267617 Methods and compositions for mycoplasma pneumoniae exotoxins
10/21/2010US20100267616 Acute respiratory syndromes
10/21/2010US20100267608 Modifications of cupredoxin derived peptides and methods of use thereof
10/21/2010US20100267146 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell
10/21/2010US20100266716 Natural Photodynamic Agents and their use
10/21/2010US20100266715 Composition for treating aids and associated conditions
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266697 Mixed ligand surface-modified nanoparticles
10/21/2010US20100266678 Cholesterol level lowering liposomes
10/21/2010US20100266668 Manufacturing Dissolvable Dosage Forms
10/21/2010US20100266654 Medical composition including an extracellular matrix particulate
10/21/2010US20100266641 Endophytic Fungi from Pteromischum Sp. Plant, Compounds and Methods of Use
10/21/2010US20100266640 Plant-Derived Cholera and Malaria Vaccine
10/21/2010US20100266639 Expression system
10/21/2010US20100266636 Method of conferring a protective immune response to norovirus
10/21/2010US20100266635 Hivcon: an hiv immunogen and uses thereof
10/21/2010US20100266634 Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus
10/21/2010US20100266633 Aids virus vaccines using sendai virus vector
10/21/2010US20100266632 Vaccine composition comprising an immunoadjuvant compound consisting of a rho gtpase family activator
10/21/2010US20100266630 Recombinant MVA virus, and the use thereof
10/21/2010US20100266629 Cattle Reproductive Disease Vaccines
10/21/2010US20100266628 Macrocyclic lactone combination compositions, vaccines and methods for producing same
10/21/2010US20100266626 Adjuvanted glucans
10/21/2010US20100266624 Hepatitis-c virus testing
10/21/2010US20100266620 Immunoconjugates for treatment of infectious diseases
10/21/2010US20100266614 Ultra high affinity neutralizing antibodies
10/21/2010US20100266611 Enhancement of Immune Responses By 4-1BB-Binding Agents
10/21/2010US20100266606 Antibody therapy for highly pathogenic avian influenza virus
10/21/2010US20100266604 Use of tam receptor inhibitors as immunoenhancers and tam activators as immunosuppressors
10/21/2010US20100266599 Human receptor proteins; related reagents and methods
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266585 Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof
10/21/2010US20100266549 Novel probiotics for pet food applications
10/21/2010US20100266543 Linked dibenzimidazole antivirals
10/21/2010US20100266539 Chemokine receptor antagonist and medical use thereof
10/21/2010US20100266537 Hcv inhibitors
10/21/2010US20100266536 new type of consensus interferon and preparation method thereof
10/21/2010US20100266535 Compounds Having CRTH2 Antagonist Activity
10/21/2010US20100266534 Human Lymphocyte Vaccine Adjuvant
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266527 Anti-microbial polymers and their compositions
10/21/2010US20100266515 Treatment of malodour
10/21/2010US20100266511 Pharmaceutical foam
10/21/2010US20100266510 Foamable Vehicle and Pharmaceutical Compositions Thereof
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/21/2010DE202010008308U1 Zusammensetzung zur nutritiven Ergänzung oder Behandlung bei Harnwegsinfekten und/oder bakteriellen Entzündungen der Schleimhäute Composition for nutritional supplement or treatment of urinary tract infections and / or bacterial inflammation of the mucous membranes
10/21/2010CA2758921A1 Meningococcal and pneumococcal conjugate vaccine and method of using same
10/21/2010CA2758852A1 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010CA2758276A1 Macrocyclic lactone combination compositions, vaccines and methods for producing same
10/20/2010EP2241625A1 Proteinase K resistant surface protein of neisseria meningitidis
10/20/2010EP2241571A1 Stable 6-methoxy-2',3'-dideoxyguanosine, method for preparing the same and pharmaceutical composition containing the same
10/20/2010EP2241564A1 3,8-diaminotetrahydroquinoline derivative
10/20/2010EP2241561A1 Neuroprotective, hypocholesterolemic and antiepileptic compound
1 ... 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 ... 1798